Lorundrostat Placebo Tablets, Lorundrostat, Synacthen 0,25 mg/ml Injektionslösung, Lorundrostat clinical trials

MLS-101-301: A Randomized, Double-Blind, Placebo Controlled, Parallel Arm, Multicenter Phase 3 Study to Evaluate the Efficacy and Safety of Lorundrostat in Subjects with Uncontrolled and Resistant Hypertension

This study is looking into a new medicine called lorundrostat for people whose high blood pressure isn't controlled by current treatments. It aims to see if lorundrostat can lower blood pressure more effectively and safely than a dummy pill (placebo) over a few weeks.